VIEMED HEALTHCARE, INC.
VMDNasdaq
$12.15
↑ +0.5%Jul 17 close · end-of-day
Price
1Y↑ +81.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$492.0M
Enterprise Value
$491.4M
P/E
32.8
P/S
1.7
P/B
3.4
EV/EBITDA
9.3
PEG
1.0
FCF Yield
5.3%
Dividend Yield
—
Revenue (TTM)
$286.6M
Net Income (TTM)
$15.4M
Free Cash Flow (TTM)
$25.9M
Gross Margin
57.6%
Operating Margin
8.2%
Net Margin
5.4%
ROE
10.7%
ROIC
11.4%
Debt / Equity
0.1
Net Cash
$557,000.00
Return 1Y
+82.2%
Company profile
Viemed Healthcare, Inc. provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP) and other small respiratory equipment; sells and rents DME and patient medical services.
- CEO
- Casey Hoyt
- Sector
- Services
- Industry
- Healthcare
- Employees
- 630
- Headquarters
- Louisiana
- Website
- viemed.com
Earnings
VMD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$75.4M↑ +27.5%
Diluted EPS$0.060.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $131.3M | $117.1M | $138.8M | $183.0M | $224.3M | $270.3M |
| Gross profit | $80.1M | $73.4M | $84.7M | $112.8M | $133.2M | $155.5M |
| Operating income | $26.8M | $11.6M | $8.3M | $14.3M | $17.9M | $22.9M |
| Net income | $31.5M | $9.1M | $6.2M | $10.2M | $11.4M | $15.4M |
| Diluted EPS | $0.78 | $0.22 | $0.16 | $0.25 | $0.28 | $0.37 |
| Operating cash flow | $35.1M | $22.5M | $27.7M | $45.2M | $39.1M | $51.9M |
| Free cash flow | $22.1M | $2.8M | $4.8M | $19.1M | $1.3M | $11.9M |
| Gross margin | 61.0% | 62.7% | 61.0% | 61.6% | 59.4% | 57.5% |
| Operating margin | 20.4% | 9.9% | 5.9% | 7.8% | 8.0% | 8.5% |
| Net margin | 24.0% | 7.8% | 4.5% | 5.6% | 5.1% | 5.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $55.0M | $58.0M | $60.7M | $59.1M | $63.1M | $71.9M | $76.2M | $75.4M |
| Gross profit | $32.9M | $34.4M | $36.1M | $33.3M | $36.7M | $41.3M | $44.1M | $42.8M |
| Operating income | $3.6M | $5.6M | $6.5M | $3.8M | $5.1M | $5.6M | $8.4M | $4.3M |
| Net income | $1.5M | $3.9M | $4.5M | $2.6M | $3.2M | $3.5M | $6.1M | $2.6M |
| Diluted EPS | $0.04 | $0.10 | $0.10 | $0.06 | $0.08 | $0.09 | $0.14 | $0.06 |
| Operating cash flow | $10.2M | $12.7M | $15.0M | $2.9M | $12.3M | $18.4M | $18.4M | $8.1M |
| Free cash flow | $1.2M | $1.7M | $3.2M | -$12.6M | $4.1M | $10.7M | $9.7M | $1.4M |
| Gross margin | 59.8% | 59.3% | 59.5% | 56.3% | 58.3% | 57.5% | 57.9% | 56.8% |
| Operating margin | 6.6% | 9.7% | 10.6% | 6.5% | 8.1% | 7.8% | 11.0% | 5.7% |
| Net margin | 2.7% | 6.7% | 7.3% | 4.4% | 5.0% | 4.9% | 8.0% | 3.4% |
Company news
Jun 10, 2026
May 27, 2026
May 12, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.